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Abstract The aim of the present study was to evaluate the effect
of iron overload on gene expression in HepG2 cells by differential
display. Iron-treated cells showed a 50% decrease in apolipo-
protein B100 (Apo B100) and a 2- and 3-fold increase in
semaphorin cd100 and aldose reductase mRNA, respectively,
with parallel variations in Apo B100 and aldose reductase
proteins. These effects were time-dependent. Vitamin E pre-
vented the increase in aldose reductase expression, but had no
effect on Apo B100 and semaphorin cd100. Treatment with
hydrogen peroxide and 4-hydroxy-2,3-nonenal increased only
aldose reductase mRNA. These data suggest that iron can affect
mRNA levels by lipid peroxidation-dependent and -independent
pathways.
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1. Introduction
Iron is essential for a series of cell activities, including cy-
tochromes and oxidases, but an excess of intracellular iron
may be toxic since it can produce highly reactive hydroxyl
radicals from H2O2, and ferryl ions by complexing with oxy-
gen [1], both of which can initiate lipid peroxidation. In turn,
lipid peroxidation of cell membranes can generate organelle
dysfunction and cell death (reviewed in [2]).
This potential toxicity requires the close regulation of iron
metabolism, a result mainly obtained by controlling the ex-
pression of the genes directly involved in iron uptake and
storage. The binding of iron regulatory proteins to the iron
regulatory elements (IREs) of transferrin receptor (TfR) and
ferritin mRNAs can control mRNA stability or the initiation
of translation, and thus regulate gene expression at a post-
transcriptional level (reviewed in [3]).
However, iron can also a¡ect the gene transcription of pro-
teins directly involved in its metabolism, as observed for fer-
ritin in primary human hepatocytes [4] and Friend leukemia
cells [5]. Moreover, increased intracellular iron levels decrease
inducible nitric oxide synthase transcription in a macrophage
cell line [6]. Iron overload also induces the expression of genes
involved in the cellular response to oxidative stress, such as
heme oxygenase 1 [7], glutathione peroxidase [8] and glycer-
aldehyde 3-phosphate dehydrogenase [9].
These iron e¡ects may be mediated by modi¢cations of
transcription factors activity, since inhibition of NF-kB and
increase in NF-IL6 activity due to iron chelation have recently
been demonstrated [10,11]. The mechanisms by which iron
a¡ects gene transcription may include oxidative stress and
lipid peroxidation. Oxidative stress activates NF-kB and acti-
vator protein-2 in rat liver [12] ; furthermore, NF-kB activa-
tion in hepatocytes can be prevented by vitamin E [13].
The aim of this study was thus to evaluate the e¡ect of iron
overload on gene expression in an in vitro model of HepG2
cells, a well-di¡erentiated cell line that maintains most hepatic
functions. The variations in mRNA levels were assessed by
means of the di¡erential display technique [14], which allows
the simultaneous evaluation of the iron-induced up- or down-
regulation of a number of genes.
2. Materials and methods
2.1. Cell cultures
HepG2 cells were grown as previously described [15] and incubated
with ferric ammonium citrate (FAC, 225 Wg/ml, or 40 Wg Fe/ml, 716
WM) for 3^7 days þK-tocopherol (vitamin E, 100 WM), or treated with
100 WM H2O2 or 15 WM 4-hydroxy-2,3-nonenal (4-HNE) for 7 or 24 h.
Cell viability was determined by means of trypan blue exclusion and
LDH release.
2.2. Iron deposition staining
HepG2 cells were rinsed four times with phosphate-bu¡ered saline
and then stained according to Scheuer et al. [16].
2.3. Lipid peroxidation assay
Lipid peroxidation products were measured using the Bioxytech
LPO-586 kit (Oxis International, Portland, OR, USA) [17] on 200
Wl of cell supernatant to which butylated hydroxytoluene was added
to a ¢nal concentration of 5 mM.
2.4. Total and poly(A)+ RNA isolation
Total RNA was extracted from the control and FAC-stimulated
HepG2 cells using the Trizol reagent (Life Technologies, Milan, Italy).
Poly(A) RNA was isolated using oligo (dT)25 magnetic beads (Dy-
nabeads oligo (dT)25, Dynal, Oslo, Norway) according to the manu-
facturer’s instructions.
2.5. cDNA synthesis and di¡erential display
Total RNA was treated with 1 U RNase-free DNase/Wg RNA (Life
Technologies, Milan, Italy) and then retrotranscribed. Di¡erential dis-
play PCR reactions were performed with a combination of 10 arbi-
trary and nine anchored oligo (dT) primers from the Delta RNA
¢ngerprinting kit (Clontech, Palo Alto, CA, USA). The PCR reaction
products were separated on 5% denaturing polyacrylamide sequencing
gels, transferred onto 3MM paper, dried under vacuum and exposed
for 18 h. The products were considered to be di¡erentially expressed
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only if the same variations were observed in reactions performed on
two di¡erent cDNAs.
2.6. Cloning and selection of cDNA fragments
Di¡erentially expressed bands were cut from the dried gels, eluted
by boiling, re-ampli¢ed and subcloned into the P-MOS vector (Amer-
sham, Milan, Italy). Twenty independent clones were randomly chos-
en for each fragment; the di¡erential clones were selected using a
modi¢cation of the reverse Northern technique [18] and then se-
quenced using the Amplicycle sequencing kit (Perkin Elmer, Monza,
Italy). The gene database searches were made at the National Center
for Biotechnology Information using the BLAST network service.
2.7. Northern blot analysis
Northern blots with total (40 Wg) or poly(A) (3 Wg) RNA were
performed as previously described [15]. The probes derived from dif-
ferential display, human TfR [19], transferrin [20], H ferritin [21],
human albumin, L-actin and ubiquitin cDNAs (ATCC, MD, USA)
were labeled with [32P]dCTP (800 mCi/mmol, Amersham, Milan,
Italy) by random priming (Megaprime kit, Amersham, Milan, Italy).
Autoradiography was quanti¢ed by computer-assisted densitometry.
2.8. Protein extraction and Western blot analysis
The proteins were extracted using the Trizol reagent (Life Technol-
ogies, Milan, Italy) and quanti¢ed by the Bradford method [22]. The
proteins (10 Wg/lane) were separated on a 12% SDS^PAGE gel under
reducing conditions [23], and electroblotted onto ECL membranes
(Amersham, Milan, Italy). Anti-human aldose reductase (gift of Dr.
Peter Kador), anti-L-actin (Sigma, Milan, Italy) and anti-human apo-
lipoprotein B100 (Apo B100) (Boehringer, Milan, Italy) were used at a
1:1000 dilution, and the horseradish peroxidase-labeled anti-rabbit
IgG, anti-mouse IgG (Amersham, Milan, Italy) and anti-goat IgG
(Sigma, Milan, Italy) at a dilution of 1:5000. The proteins detected
using the speci¢c antibodies were visualized by chemoluminescence
(ECL, Amersham, Milan, Italy), and the bands quanti¢ed by com-
puter-assisted densitometry.
2.9. Data analysis
Data comparison was performed using the Student^Newman^Keuls
test.
3. Results
Seven days FAC treatment at a ¢nal Fe concentration of 40
Wg/ml (712 WM) induced iron overload as assessed by Pearls’
staining (50% positive cells) without a¡ecting cell viability
(s 90%). Moreover, there was a more than 90% reduction
in the level of TfR mRNA after 1 week of iron overloading,
an e¡ect that was already present after 3 days of treatment
(Fig. 1, lanes Fe+/Vit. E3). Iron supplementation did not
have a toxic e¡ect on the HepG2 cells, since there was no
signi¢cant variation in albumin mRNA levels (Fig. 1), being,
at 7 days, 92 þ 3.2% and 89.5 þ 4.5% for Fe+/Vit. E3 and
Fe+/Vit. E+, respectively. Moreover, no signi¢cant decrease
Fig. 1. TfR and albumin (Alb) expression in response to iron treat-
ment. Total RNA isolated from HepG2 cells left untreated (Fe3/
Vit. E3), or cultured in the presence of iron (Fe+/Vit. E3) or iron
and vitamin E (Fe+/Vit. E+) for 3, 5 and 7 days (d) was hybridized
with TfR, albumin and ubiquitin (Ubi) cDNA. Autoradiographies
are representative of at least three independent experiments.
Fig. 2. Di¡erential display and Northern blot analysis of di¡eren-
tially expressed clones. Autoradiography of polyacrylamide denatur-
ing gels with di¡erential display PCR products obtained from con-
trol (C) or iron-overloaded cell cDNA (Fe) (A, B and C). The
arrows indicate the di¡erential bands which corresponded to Apo
B100 (A), semaphorin cd100 (B) and aldose reductase (C). Northern
blot hybridization on poly(A) RNA with Apo B100 (a), semaphor-
in cd100 (b), aldose reductase (c) and ubiquitin cDNAs (d^f).
Fig. 3. Northern blot analysis of Apo B100, semaphorin cd100 and
aldose reductase expression after iron treatment þ vitamin E. Toal
RNA isolated from HepG2 cells left untreated (Fe3/Vit. E3), or
cultured in the presence of iron (Fe+/Vit. E3) or iron and vitamin
E (Fe+/vit. E+) for 3, 5 and 7 days (d) was hybridized with Apo
B100 (Apo), semaphorin cd100 (Sem), aldose reductase (Ald) and
ubiquitin (Ubi) cDNAs. Autoradiographies are representative of at
least three independent experiments.
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was observed in the mRNA levels of transferrin and H ferritin
(data not shown).
The RNAs from control and iron-loaded HepG2 cells were
analyzed using the di¡erential display technique and, after
reverse Northern screening, 16 bands were identi¢ed as being
di¡erentially represented: four of these bands were more
abundant in the controls and the remaining 12 in the iron-
overloaded samples. Of the ¢nal 16 independent clones, two
corresponded to di¡erent regions of Apo B100 cDNA (from
5614 to 6202 bp and from 9885 to 10 030 bp), two to sema-
phorin cd100 cDNA (from 741 to 1033 bp and from 3480 to
3886 bp), and one to the 3P end region of the aldose reductase
transcript (from 1179 to 1335 bp). The other 11 clones showed
homology with expressed sequence tags, and are currently
under investigation.
The di¡erential display reactions identifying the three
known genes are shown in Fig. 2. Northern blot hybridization
on poly(A) RNA con¢rmed the di¡erential representation of
all three mRNAs (Fig. 2a^c), with an increase in semaphorin
cd100 and aldose reductase mRNAs and a decrease in the
Apo B100 transcript.
The e¡ects of iron overloading (40 Wg/ml of Fe) at di¡erent
times (3, 5 and 7 days) on Apo B100, semaphorin cd100 and
aldose reductase mRNAs, as well as those of the concomitant
administration of vitamin E, are shown in Fig. 3. The inten-
sity of the hybridized bands was normalized for di¡erences in
loading and the e¡ect of the iron overload is graphically rep-
resented in Fig. 4. An initial increase in aldose reductase and
semaphorin cd100 mRNAs was evident after 3 days of iron
treatment; the e¡ect on Apo B100 appeared after 5 days.
However, the e¡ect of iron overload on gene expression was
more pronounced after 7 days of treatment (Fig. 3, 7d, lanes
Fe+/Vit. E3, and Fig. 4). Iron treatment reduced the level of
Apo B100 mRNA by approximately 50%, whereas the levels
of semaphorin cd100 and aldose reductase mRNAs respec-
tively doubled and tripled (P6 0.05 vs. controls). Parallel
treatment with ammonium citrate alone was not able to in-
duce changes in the mRNA levels of any of the genes analyzed
(data not shown).
After 7 days of iron treatment, lipid peroxidation product
levels of 9.8 þ 1.1 WM were observed, but none was detectable
in the controls or the supernatants of the cells treated with
iron and vitamin E, thus demonstrating both the presence of
iron-induced lipid peroxidation and the e⁄cacy of the anti-
oxidant treatment. Antioxidant had no e¡ect on albumin
mRNA or on the iron-induced reduction in TfR mRNA
(Fig. 1, lanes Fe+/Vit. E+), whereas it almost completely pre-
vented the induction of aldose reductase mRNA at 3, 5 and
7 days (Fig. 3, lanes Fe+/Vit. E+ and Fig. 4), without any
signi¢cant e¡ect on the iron-induced modi¢cation in Apo
B100 and semaphorin cd100 mRNA levels (Ps 0.05 vs. iron
treatment alone).
The changes in aldose reductase and Apo B100 protein
levels paralleled the variations in mRNA at 3, 5 and 7 days.
Semaphorin cd100 protein level was not assessed due to the
unavailability of speci¢c antibodies. Vitamin E treatment had
Fig. 4. Quantitative analysis of Apo B100, semaphorin cd100 and
aldose reductase mRNA levels after iron treatment þ vitamin E.
HepG2 cells were left untreated (Fe3/Vit. E3), or cultured in the
presence of iron (Fe+/Vit. E3) (b) or iron plus vitamin E (Fe+/Vit.
E+) (a) for 1, 3, 5 and 7 days. The mRNA levels of Apo B100
(Apo), semaphorin cd100 (Sem) and aldose reductase (Ald) were
quanti¢ed by densitometry and normalized using ubiquitin and L-ac-
tin hybridizations. The mRNA levels from untreated cells were
arbitrarily set at 100%. The results are the mean values þ S.E.M.
of at least three independent experiments. *P6 0.05 vs. controls,
**P6 0.05 vs. iron overload.
Fig. 5. Western blot analysis of aldose reductase (Ald) and Apo
B100 (Apo) expression after iron treatment þ vitamin E. The HepG2
cells were left untreated (Fe3/Vit. E3), or cultured in the presence
of iron (Fe+/Vit. E3) or iron plus vitamin E (Fe+/Vit. E+) for 1,
3, 5 and 7 days (d). Proteins from the cell extracts (for aldose re-
ductase and L-actin analysis) or culture media (for Apo B100) were
separated on SDS^PAGE, electroblotted on a membrane and
probed with speci¢c antibodies. Results are representative of three
independent experiments.
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no signi¢cant e¡ect on Apo B100 protein levels, but prevented
aldose reductase induction (Fig. 5, lanes Fe+/Vit. E+).
In order to assess the role of oxidative stress and lipid
peroxidation products in the observed variations in gene ex-
pression, HepG2 cells were stimulated for 7 and 24 h with
hydrogen peroxide and 4-HNE. No changes in Apo B100 or
semaphorin cd100 mRNA were observed, whereas treatment
with 4-HNE or H2O2 for 24 h (but not for 7 h) induced aldose
reductase mRNA (Fig. 6).
4. Discussion
Iron can control the expression of the genes directly in-
volved in its metabolism, such as TfR and ferritin [3]; this
regulation takes place at the post-transcriptional level and, in
the case of TfR, involves mRNA degradation.
However, the use of di¡erential display allowed us to iden-
tify the e¡ects of iron overload on the expression of genes
other than those directly involved in its metabolism. Treat-
ment with FAC induced a large increase in intracellular iron,
and a signi¢cant reduction in TfR mRNA, without impairing
cell viability or hepatic synthesis. The lack of induction of
ferritin mRNA con¢rms also what was previously observed
by Hubart et al. [4], thus supporting the presence of a post-
transcriptional regulation of ferritin synthesis in these cells.
The di¡erential display analysis identi¢ed the modulation of
several transcripts, including Apo B100, semaphorin cd100
and aldose reductase.
Apo B100 is the major protein component of VLDL and
LDL, and is essential for maintaining normal lipid metabo-
lism [24]. In our experimental system, Apo B100 mRNA de-
creased by 50% after 1 week of iron treatment, and parallel
changes were observed at the protein level. These data support
the presence of an interaction between iron and lipid metab-
olism, as has also recently been reported by Brunet et al. [25],
by using an in vivo model.
It is known that iron overload can induce free radical for-
mation and lipid peroxidation in the liver [26], and in agree-
ment to what was previously reported [27], we found that
peroxidation products reached levels of 10 WM in the presence
of iron, whereas vitamin E treatment inhibited lipid damage.
The addition of the antioxidant had only a slight e¡ect on the
iron-induced reduction in Apo B100 mRNA and protein.
Moreover, the reduction in Apo B100 mRNA was not due
to a generalized toxic e¡ect, as previously observed in iron-
overloaded rats where hepatic functions were not altered [28].
Conversely, iron loading led to an increase in the mRNA
levels of semaphorin cd100 and aldose reductase genes. Sem-
aphorin cd100 is a recently identi¢ed gene whose expression
has previously been described in other tissues, but not in the
liver [29] ; we found a very low but detectable level of mRNA
in untreated HepG2 cells, which was increased by iron stim-
ulation. As in the case of Apo B100, this e¡ect was not altered
by the addition of vitamin E, thus suggesting that free radicals
and lipid peroxidation are not directly involved in the modu-
lation. Semaphorin cd100 expression promotes B-cell survival
[29], but its precise function still remains to be de¢ned in other
tissues. It is interesting to note that overexpression of sema-
phorin E, another protein belonging to the same family, could
be related to cell defence mechanisms [30,31].
Iron overloading tripled the mRNA and protein levels of
aldose reductase, an NADPH-dependent aldo-keto reductase
that converts glucose to sorbitol in the polyol pathway, but
can also reduce 4-HNE, one of the major products of lipid
peroxidation [32]. It has been shown that 4-HNE or H2O2
treatment of smooth muscle vascular cells can lead to a sig-
ni¢cant increase in aldose reductase mRNA [33,34]. These
¢ndings suggest that aldose reductase may act as a detoxifying
enzyme. In this regard, the results of the present study indi-
cate that aldose reductase expression may be a response to the
lipid peroxidation induced by iron overload in HepG2 cells.
This is supported by the observed ability of vitamin E to
prevent, and 4-HNE to induce, the increase in aldose reduc-
tase mRNA.
Conversely, a mechanism independent from the generation
of free radical formation and lipid peroxidation can be hy-
pothesized for either Apo B100 or semaphorin cd100.
In conclusion, there are a number of pathways by means of
which iron overload can induce variations in the mRNA levels
of genes other than those directly involved in its metabolism.
Further studies are necessary to assess whether iron acts on
transcription rates (by activating NF-kB or other factors) or
mRNA stability.
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